Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Jan. 29, 2026. Document 2026-01817. Updated Nov. 15, 2026.
- What it does
This request for information seeks input from the public on whether any additions or modifications are needed to the safe harbor regulations under the Federal anti-kickback statute or the exceptions to the civil monetary penalty provision prohibiting inducements to beneficiaries (the "Beneficiary Inducements CMP") for emerging direct-to-consumer ("DTC") sales programs established by pharmaceutical manufacturers, including those that will be available through TrumpRx.
The Inspector General Office, Health and Human Services Department's summary, as published in the Federal Register.
- What it would change
2 parts of Title 42 of the Code of Federal Regulations:
- Before this
No earlier Federal Register document under regulation identifier 0936-AA15 since Jan. 1, 2025.
- What happens next and when
To ensure consideration, comments must be received no later than 5 p.m. on March 30, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-01817 |
|---|---|
| Action | Request for information. |
| Agencies | Health and Human Services Department; Inspector General Office, Health and Human Services Department |
| Published | Jan. 29, 2026 |
| Comments close | March 30, 2026 |
| Regulation identifier (RIN) | 0936-AA15 |
| Docket | HHSIG-2026-0001 |
Source: the Federal Register (public domain). The document in the Federal Register